Nomogram for BPH progression risk offers aid in clinical decision-making


Chicago-Data from nearly 5,000 participants in the phase III studiesof dutasteride (Avodart) have been used to develop a nomogram for predictingthe probability that an individual patient with BPH will develop acute urinaryretention or require surgical intervention within 2 years and how that riskmay be altered by initiating dutasteride therapy.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.